TABLE 1.
Characteristics | Cerebral Venous Thrombosis (N=45) | Ischemic Stroke (N=9) | Hemorrhagic Stroke (N=4) | Other (N=4) | Total (N=62) |
---|---|---|---|---|---|
Age | |||||
Mean (SD) | 44.3 (17.0) | 55.6 (17.9) | 42.8 (13.2) | 57.2 (12.9) | 46.7 (17.1) |
Median | 43 | 56 | 47 | 59.5 | 46 |
Range | 20.0–89.0 | 31.0–82.0 | 24.0–53.0 | 41.0–69.0 | 20.0–89.0 |
Age category | |||||
<60 | 36 (80.0%) | 6 (66.7%) | 4 (100.0%) | 2 (50.0%) | 48 (77.4%) |
60+ | 9 (20.0%) | 3 (33.3%) | 0 (0.0%) | 2 (50.0%) | 14 (22.6%) |
Sex | |||||
Female | 35 (77.8%) | 6 (66.7%) | 3 (75.0%) | 3 (75.0%) | 47 (75.8%) |
Male | 10 (22.2%) | 3 (33.3%) | 1 (25.0%) | 1 (25.0%) | 15 (24.2%) |
Smoking | |||||
N‐Miss | 6 | 1 | 2 | 1 | 10 |
Yes | 3 (7.7%) | 2 (25.0%) | 0 (0.0%) | 1 (33.3%) | 6 (11.5%) |
No | 36 (92.3%) | 6 (75.0%) | 2 (100.0%) | 2 (66.7%) | 46 (88.5%) |
Obese | |||||
N‐Miss | 2 | 0 | 0 | 1 | 3 |
No | 41 (95.3%) | 8 (88.9%) | 4 (100.0%) | 3 (100.0%) | 56 (94.9%) |
Yes | 2 (4.7%) | 1 (11.1%) | 0 (0.0%) | 0 (0.0%) | 3 (5.1%) |
History of thrombosis | |||||
N‐Miss | 2 | 0 | 0 | 1 | 3 |
No | 42 (97.7%) | 9 (100.0%) | 4 (100.0%) | 3 (100.0%) | 58 (98.3%) |
Yes | 1 (2.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.7%) |
Vaccine | |||||
ChAdOx1 | 37 (82.2%) | 8 (88.9%) | 4 (100.0%) | 4 (100.0%) | 53 (85.5%) |
BNT162b2 | 8 (17.8%) | 1 (11.1%) | 0 (0.0%) | 0 (0.0%) | 9 (14.5%) |
mRNA‐1273 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Vaccination Status | |||||
First shot | 42 (93.3%) | 9 (100.0%) | 4 (100.0%) | 4 (100.0%) | 59 (95.2%) |
Second shot | 3 (6.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 3 (4.8%) |